Ganirelix Acetate Injection



Indications and Reactions:

Role Indications Reactions
Primary
In Vitro Fertilisation 30.0%
Infertility 28.8%
Assisted Fertilisation 12.5%
Prevention Of Premature Ovulation 10.0%
Ovulation Induction 6.3%
Product Used For Unknown Indication 6.3%
Anovulatory Cycle 2.5%
Blood Luteinising Hormone Abnormal 2.5%
Prophylaxis 1.3%
Drug Ineffective 15.1%
Needle Issue 13.2%
No Adverse Event 11.3%
Product Quality Issue 7.5%
Injection Site Urticaria 5.7%
Underdose 5.7%
Anaphylactic Reaction 3.8%
Ectopic Pregnancy 3.8%
Low Birth Weight Baby 3.8%
Maternal Exposure During Pregnancy 3.8%
Ovarian Hyperstimulation Syndrome 3.8%
Respiratory Distress 3.8%
Skin Irritation 3.8%
Treatment Noncompliance 3.8%
Abortion Missed 1.9%
Air Embolism 1.9%
Anaphylactic Shock 1.9%
Blood Human Chorionic Gonadotropin Increased 1.9%
Caesarean Section 1.9%
Cardiovascular Insufficiency 1.9%
Secondary
In Vitro Fertilisation 24.0%
Infertility 17.3%
Product Used For Unknown Indication 15.1%
Ill-defined Disorder 14.0%
Ovulation Induction 10.6%
Ovarian Hyperstimulation Syndrome 5.0%
Anaesthesia 2.2%
Assisted Fertilisation 1.7%
Prophylaxis 1.7%
Hormone Suppression Therapy 1.1%
Luteal Phase Deficiency 1.1%
Oocyte Donation 1.1%
Ovarian Hyperfunction 1.1%
Routine Health Maintenance 1.1%
Constipation 0.6%
Infertility Female 0.6%
Pregnancy 0.6%
Prevention Of Premature Ovulation 0.6%
Vitamin Supplementation 0.6%
Ectopic Pregnancy 31.1%
Ovarian Hyperstimulation Syndrome 15.6%
Deep Vein Thrombosis 8.9%
Cytogenetic Abnormality 4.4%
Eosinophilic Pneumonia Acute 4.4%
Hypoxia 4.4%
Abdominal Pain 2.2%
Abortion Induced 2.2%
Abortion Spontaneous 2.2%
Drug Ineffective 2.2%
Dyspnoea 2.2%
Effusion 2.2%
Emotional Disorder 2.2%
Feeling Abnormal 2.2%
Genital Herpes 2.2%
Hyponatraemia 2.2%
Limb Discomfort 2.2%
Low Density Lipoprotein Increased 2.2%
Maternal Exposure Before Pregnancy 2.2%
Metrorrhagia 2.2%
Concomitant
In Vitro Fertilisation 28.9%
Product Used For Unknown Indication 20.7%
Assisted Fertilisation 6.6%
Ovarian Disorder 6.6%
Ovarian Hyperstimulation Syndrome 4.1%
Drug Use For Unknown Indication 3.3%
Ovulation Induction 3.3%
Supplementation Therapy 3.3%
Vitamin Supplementation 3.3%
Thyroid Disorder 2.5%
Vitamin D Deficiency 2.5%
Blood Follicle Stimulating Hormone Abnormal 1.7%
Gastrooesophageal Reflux Disease 1.7%
Mineral Supplementation 1.7%
Oestrogen Replacement Therapy 1.7%
Polycystic Ovaries 1.7%
Premenstrual Syndrome 1.7%
Prophylaxis 1.7%
Sedative Therapy 1.7%
Superovulation 1.7%
Ovarian Hyperstimulation Syndrome 21.2%
Premature Baby 9.1%
Antepartum Haemorrhage 6.1%
Emotional Distress 6.1%
Rectal Tenesmus 6.1%
Thinking Abnormal 6.1%
Twin Pregnancy 6.1%
Aspartate Aminotransferase Increased 3.0%
Cholelithiasis 3.0%
Dizziness 3.0%
Drug Exposure During Pregnancy 3.0%
Hypoaesthesia 3.0%
Liver Function Test Abnormal 3.0%
Mental Disorder 3.0%
Mood Altered 3.0%
Oestradiol Decreased 3.0%
Off Label Use 3.0%
Pleural Effusion 3.0%
Pregnancy 3.0%
Pregnancy Test Positive 3.0%